drugset / Trial / NCT07040280

Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma

NCT07040280 ↗

Phase 2 Recruiting 120 enrolled ECOG-ACRIN Cancer Research Group
RandomizedParallel-groupDouble-blindPrevention

Summary

This phase II trial tests how well sulforaphane works in preventing melanoma in patients with multiple atypical moles (nevi) and a prior history of melanoma. Patients with a history of melanoma and multiple atypical nevi are at a significantly increased risk of developing additional melanomas than those without atypical nevi. Prevention measures usually include sun protection, monthly skin self-examinations and regular skin examinations from a doctor. Sulforaphane is a naturally-occurring substance found in many cruciferous vegetables, including broccoli, that may prevent melanoma from forming.

Timeline

Start
2026-02-20
Primary completion
2031-03-01
Completion
2033-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulforaphane Small molecule — Oral